TORONTO, May 16 /CNW/ - ARIUS Research Inc., (TSX: ARI), a biotechnology
company discovering and developing the next wave of antibody therapeutics,
today responded to an inquiry by Market Regulation Services of the Toronto
Stock Exchange, regarding market activity of the Company's shares.
